“`html
{
"@context": "https://schema.org",
"@type": "FAQPage",
"mainEntity":[
{
"@type": "Question",
"name": "When will Regeneron announce its Q2 2025 financial results?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Regeneron Pharmaceuticals plans to release its second quarter 2025 financial results before the U.S. financial markets open on Friday,August 1,2025."
}
},
{
"@type": "Question",
"name": "How can I listen to the Regeneron conference call?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Interested parties can access the live webcast through the 'Investors and Media' section of Regeneron's website.A telephone option is also available by registering in advance to receive dial-in details and a unique passcode."
}
},
{
"@type": "Question",
"name": "Where can I find a replay of the Regeneron conference call?",
"acceptedAnswer": {
"@type": "Answer",
"text": "A replay and transcript of the conference call and webcast will be available on Regeneron's website for a minimum of 30 days following the call."
}
},
{
"@type": "Question",
"name": "What type of company is Regeneron?",
"acceptedAnswer": {
"@type": "answer",
"text": "regeneron Pharmaceuticals (NASDAQ: REGN) is a leading biotechnology firm focused on inventing, developing, and commercializing medicines for individuals with serious illnesses."
}
},
{
"@type": "Question",
"name": "What therapeutic areas does Regeneron focus on?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Regeneron's medicines and pipeline are geared toward helping patients with eye diseases, allergic and inflammatory conditions, cancer, cardiovascular and metabolic disorders, neurological issues, hematologic conditions, infectious diseases, and
